The effects of modifications of lysyl and arginyl groups on the biological and immunological activity of human chorionic gonadotropin.
D000818:Animals; D001120:Arginine; D001681:Biological Assay; D006063:Chorionic Gonadotropin / Q000276:immunology / Q000494:pharmacology*; D003512:Cyclohexanones / Q000494:pharmacology; D000939:Epitopes / Q000032:analysis*; D007106:Immune Sera; D008239:Lysine; D046911:Macromolecular Substances; D008297:Male; D011467:Prostate / Q000187:drug effects; D011863:Radioimmunoassay; D051381:Rats; D013329:Structure-Activity Relationship; D013387:Succinic Anhydrides / Q000494:pharmacology
D006063:Chorionic Gonadotropin; D003512:Cyclohexanones; D000939:Epitopes; D007106:Immune Sera; D046911:Macromolecular Substances; D013387:Succinic Anhydrides; C031801:succinic anhydride; C018031:1,2-cyclohexanedione; D001120:Arginine; D008239:Lysine